{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:23:08Z","timestamp":1780950188327,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,18]]},"DOI":"10.7759\/cureus.33916","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:05:57Z","timestamp":1674043557000},"source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Impact of Type 2 Diabetes in Metastatic Colorectal Cancer"],"prefix":"10.7759","author":[{"given":"Mafalda","family":"Miranda Baleiras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Dias Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Vasques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor","family":"Vasconcelos de Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi P","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019, 157:107843. 10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan MA","year":"2020","unstructured":"Khan MA, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020, 10:107-11. 10.2991\/jegh.k.191028.001","journal-title":"J Epidemiol Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1747326","article-title":"Diabetes and colorectal cancer risk: clinical and therapeutic implications","volume":"2022","author":"Yu GH","year":"2022","unstructured":"Yu GH, Li SF, Wei R, Jiang Z. Diabetes and colorectal cancer risk: clinical and therapeutic implications. J Diabetes Res. 2022, 2022:1747326. 10.1155\/2022\/1747326","journal-title":"J Diabetes Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2673","article-title":"Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis","volume":"9","author":"Wang J","year":"2020","unstructured":"Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med. 2020, 9:361-73. 10.1002\/cam4.2673","journal-title":"Cancer Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes A","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al.. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023, 34:10-32. 10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212409","article-title":"Diabetes and colorectal cancer risk: a new look at molecular mechanisms and potential role of novel antidiabetic agents","volume":"22","author":"Vekic J","year":"2021","unstructured":"Vekic J, Zeljkovic A, Stefanovic A, Giglio RV, Ciaccio M, Rizzo M. Diabetes and colorectal cancer risk: a new look at molecular mechanisms and potential role of novel antidiabetic agents. Int J Mol Sci. 2021, 22:12409. 10.3390\/ijms222212409","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101089","article-title":"Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes","volume":"14","author":"Cheng HC","year":"2021","unstructured":"Cheng HC, Chang TK, Su WC, Tsai HL, Wang JY. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Transl Oncol. 2021, 14:101089. 10.1016\/j.tranon.2021.101089","journal-title":"Transl Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03861-7","article-title":"Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries","volume":"148","author":"Roderburg C","year":"2022","unstructured":"Roderburg C, Loosen SH, Hoyer L, Luedde T, Kostev K. Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries. J Cancer Res Clin Oncol. 2022, 148:1057-62. 10.1007\/s00432-021-03861-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16677-3","article-title":"The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus","volume":"12","author":"Tarhini Z","year":"2022","unstructured":"Tarhini Z, Manceur K, Magne J, Mathonnet M, Jost J, Christou N. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Sci Rep. 2022, 12:12374. 10.1038\/s41598-022-16677-3","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz078","article-title":"Diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance)","volume":"4","author":"Brown JC","year":"2020","unstructured":"Brown JC, Zhang S, Ou FS, et al.. Diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance). JNCI Cancer Spectr. 2020, 4:pkz078. 10.1093\/jncics\/pkz078","journal-title":"JNCI Cancer Spectr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/13813450802008455","article-title":"Type 2 diabetes mellitus as risk factor for colorectal cancer","volume":"114","author":"Berster JM","year":"2008","unstructured":"Berster JM, G\u00f6ke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem. 2008, 114:84-98. 10.1080\/13813450802008455","journal-title":"Arch Physiol Biochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102857","article-title":"Impact of adiposity on staging and prognosis of colorectal cancer","volume":"145","author":"Silva A","year":"2020","unstructured":"Silva A, Faria G, Ara\u00fajo A, Monteiro MP. Impact of adiposity on staging and prognosis of colorectal cancer. Crit Rev Oncol Hematol. 2020, 145:102857. 10.1016\/j.critrevonc.2019.102857","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin X","year":"2020","unstructured":"Lin X, Xu Y, Pan X, et al.. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020, 10:14790. 10.1038\/s41598-020-71908-9","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a meta-analysis","volume":"97","author":"Larsson SC","year":"2005","unstructured":"Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005, 97:1679-87. 10.1093\/jnci\/dji375","journal-title":"J Natl Cancer Inst"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1989.tb02244.x","article-title":"Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26","volume":"80","author":"Koenuma M","year":"1989","unstructured":"Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res. 1989, 80:51-8. 10.1111\/j.1349-7006.1989.tb02244.x","journal-title":"Jpn J Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.13.972","article-title":"Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer","volume":"94","author":"Sandhu MS","year":"2002","unstructured":"Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002, 94:972-80. 10.1093\/jnci\/94.13.972","journal-title":"J Natl Cancer Inst"},{"key":"ref17","article-title":"Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients","volume":"123","author":"Chen CQ","year":"2010","unstructured":"Chen CQ, Fang LK, Cai SR, et al.. Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J (Engl). 2010, 123:3084-8.","journal-title":"Chin Med J (Engl)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.737330","article-title":"Diabetes and risks of right-sided and left-sided colon cancer: a meta-analysis of prospective cohorts","volume":"12","author":"Xiao W","year":"2022","unstructured":"Xiao W, Huang J, Zhao C, Ding L, Wang X, Wu B. Diabetes and risks of right-sided and left-sided colon cancer: a meta-analysis of prospective cohorts. Front Oncol. 2022, 12:737330. 10.3389\/fonc.2022.737330","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a focused review of literature","volume":"11","author":"Baran B","year":"2018","unstructured":"Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterology Res. 2018, 11:264-73. 10.14740\/gr1062w","journal-title":"Gastroenterology Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13122","article-title":"Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions","volume":"16","author":"Ottaiano A","year":"2022","unstructured":"Ottaiano A, Circelli L, Santorsola M, et al.. Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions. Mol Oncol. 2022, 16:319-32. 10.1002\/1878-0261.13122","journal-title":"Mol Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34015","article-title":"Diabetes mellitus in relation to colorectal tumor molecular subtypes: a pooled analysis of more than 9000 cases","volume":"151","author":"Harlid S","year":"2022","unstructured":"Harlid S, Van Guelpen B, Qu C, et al.. Diabetes mellitus in relation to colorectal tumor molecular subtypes: a pooled analysis of more than 9000 cases. Int J Cancer. 2022, 151:348-60. 10.1002\/ijc.34015","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e3182a479f9","article-title":"Diabetes mellitus and colorectal cancer prognosis: a meta-analysis","volume":"56","author":"Mills KT","year":"2013","unstructured":"Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013, 56:1304-19. 10.1097\/DCR.0b013e3182a479f9","journal-title":"Dis Colon Rectum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.68","article-title":"Diabetes and prognosis in older persons with colorectal cancer","volume":"110","author":"Luo J","year":"2014","unstructured":"Luo J, Lin HC, He K, Hendryx M. Diabetes and prognosis in older persons with colorectal cancer. Br J Cancer. 2014, 110:1847-54. 10.1038\/bjc.2014.68","journal-title":"Br J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-10-76","article-title":"The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer","volume":"10","author":"Huang CW","year":"2012","unstructured":"Huang CW, Sun LC, Shih YL, et al.. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol. 2012, 10:76. 10.1186\/1477-7819-10-76","journal-title":"World J Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.06.009","article-title":"For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis","volume":"44","author":"Cheng Y","year":"2020","unstructured":"Cheng Y, Chen Y, Zhou C, Shen L, Tu F, Xu J, Liu C. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis. Clin Res Hepatol Gastroenterol. 2020, 44:73-81. 10.1016\/j.clinre.2019.06.009","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31305","article-title":"Association between metformin use after surgery for colorectal cancer and oncological outcomes: a nationwide register-based study","volume":"143","author":"Fransgaard T","year":"2018","unstructured":"Fransgaard T, Thygesen LC, G\u00f6genur I. Association between metformin use after surgery for colorectal cancer and oncological outcomes: a nationwide register-based study. Int J Cancer. 2018, 143:63-72. 10.1002\/ijc.31305","journal-title":"Int J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/133199-prognostic-impact-of-type-2-diabetes-in-metastatic-colorectal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:13Z","timestamp":1707508093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/133199-prognostic-impact-of-type-2-diabetes-in-metastatic-colorectal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.33916","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}